Clinical and biochemical effects of chronic reserpine administration in mongrel dogs.
D000284:Administration, Oral; D000771:Anesthesia, Intravenous; D000818:Animals; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D002540:Cerebral Cortex / Q000032:analysis; D004285:Dogs; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D007031:Hypothalamus / Q000032:analysis; D008526:Medulla Oblongata / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D010424:Pentobarbital; D011149:Pons / Q000032:analysis; D012110:Reserpine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D012701:Serotonin / Q000032:analysis; D013564:Sympathetic Nervous System / Q000187:drug effects; D013997:Time Factors
D001786:Blood Glucose; D006454:Hemoglobins; D012701:Serotonin; D012110:Reserpine; D010424:Pentobarbital; D001663:Bilirubin; D009638:Norepinephrine